GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Debt-to-Asset

Qyuns Therapeutics Co (HKSE:02509) Debt-to-Asset : 0.47 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Debt-to-Asset?

Qyuns Therapeutics Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$203.8 Mil. Qyuns Therapeutics Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$335.5 Mil. Qyuns Therapeutics Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was HK$1,157.0 Mil. Qyuns Therapeutics Co's debt to asset for the quarter that ended in Jun. 2024 was 0.47.

Qyuns Therapeutics Co Debt-to-Asset Historical Data

The historical data trend for Qyuns Therapeutics Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Debt-to-Asset Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
0.27 0.29 0.44 0.54

Qyuns Therapeutics Co Quarterly Data
Dec21 Dec22 Sep23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial 0.29 0.38 0.44 0.47 0.54

Competitive Comparison of Qyuns Therapeutics Co's Debt-to-Asset

For the Biotechnology subindustry, Qyuns Therapeutics Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qyuns Therapeutics Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Qyuns Therapeutics Co's Debt-to-Asset falls into.


;
;

Qyuns Therapeutics Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Qyuns Therapeutics Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(226.35 + 336.949) / 1050.458
=0.54

Qyuns Therapeutics Co's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(203.767 + 335.503) / 1156.982
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qyuns Therapeutics Co  (HKSE:02509) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Qyuns Therapeutics Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Qyuns Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Debt-to-Asset
Comparable Companies
HKSE:01521 HKSE:01541 HKSE:06978 HKSE:01167 HKSE:02181 HKSE:02487 HKSE:06996 HKSE:01873 HKSE:02563 HKSE:03681 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Website
http://www.qyuns.net
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Executives
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Jian Xin Chuang Ye Tou Zi You Xian Gong Si 2101 Beneficial owner
Hang Zhou Zhong Mei Hua Dong Zhi Yao You Xian Gong Si 2101 Beneficial owner
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Yuan Da Hua Chuang Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Hua Dong Yi Yao Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Qiu Jiwan
Xu Qiu
Hangzhou Quanyi Investment Management Partnership (general Partnership)
Yu Guo'an
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Sheng Xi Tai

Qyuns Therapeutics Co Headlines

No Headlines